Article
Differences in Clinical Presentation, Severity, and Treatment of COVID-19 Among Individuals with Down Syndrome from India and High-Income Countries: Data from the Trisomy 21 Research Society Survey
2022-04-11
Abstract excerpt
Background: Collectively, people with Down syndrome (DS) are one of the highest risk groups for mortality associated with COVID-19, but outcomes may differ across countries due to different co-morbidity profiles and exposures, which could have implications for disease management. The present study is designed to identify differences in clinical presentation, severity, and treatment of COVID-19 between India and a...
Topics
Open a Topic to create a Post that cites this publication.
- Adolescent and Pediatric Healthcare
- COVID-19 Clinical Research Studies
- Diabetes and associated disorders
- Down syndrome and intellectual disability research
- Genomic variations and chromosomal abnormalities
- Immunodeficiency and Autoimmune Disorders
- Kawasaki Disease and Coronary Complications
- Neonatal and Maternal Infections
Identifiers and source
- Literature Corpus work
- 2ac22aff-107a-5897-81ad-7d69e9051c8d
- DOI
- 10.2139/ssrn.4081069
